Diego de Araujo Toloi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Phase I trials are an important step in the development of new drugs. Because of the advancing knowledge of cancer's molecular biology, these trials offer an important platform for the development of new agents and also for patient treatment. Therefore, comprehension of their peculiar terminology and methodology are increasingly important. Our objectives(More)
BACKGROUND Cancer can influence the views of patients on treatment goals and make them different from those of health care professionals (HCPs). It is crucial to understand patient expectations regarding cancer treatment. METHODS We performed a cross-sectional survey of patients with cancer and HCPs to evaluate their perceptions about treatment priorities(More)
  • 1